Millennium Management’s Coherus Oncology CHRS Stock Holding History

Millennium Management’s Portfolio CHRS Stock Details CHRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-104,200	Closed	-$1.46M	–	3935
2018 Q2	$1.46M	Buy	+104,200	New	+$1.49M	﹤0.01%	2615
2016 Q4	–	Sell	-100,000	Closed	-$2.68M	–	3367
2016 Q3	$2.68M	Buy	+100,000	New	+$2.73M	﹤0.01%	1747
2015 Q4	–	Sell	-50,000	Closed	-$1M	–	3445
2015 Q3	$1M	Buy	+50,000	New	+$1.52M	﹤0.01%	2282

Other funds holding CHRS

TGY2IT

Timothy G. Youngquist 2020 Irrevocable Trust Fort Myers, Florida $510M AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return

CWG

C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return

Millennium Management's CHRS Position: Q2 2026 in Review

Millennium Management reduced its Coherus Oncology (CHRS) stake by 93% in Q2 2026, selling an estimated $475K and leaving 20,749 shares worth $29K. The position accounts for ﹤0.01% of the portfolio, ranked #5661.

Millennium Management first reported a position in CHRS in Q1 2015 and has held it in 39 quarters since. The position peaked at $27M in Q3 2016. 147 funds tracked by Wall St. Rank hold CHRS as of Q2 2026.

Millennium Management held 20,749 shares of Coherus Oncology worth $29K as of Q2 2026.
Millennium Management sold 291,237 Coherus Oncology shares in Q2 2026, an estimated $475K.
Coherus Oncology made up ﹤0.01% of Millennium Management's portfolio in Q2 2026, its #5661 holding.
Millennium Management first reported a position in Coherus Oncology in Q1 2015 and has held it in 39 quarters since.
Millennium Management's Coherus Oncology position peaked at $27M in Q3 2016.
147 funds tracked by Wall St. Rank held Coherus Oncology as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.